← Autolus Therapeutics plc
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income From Continuing Operations | — | — | ($44.8m) | ($123.8m) | ($142.1m) | ($142.1m) | ($148.8m) | ($208.4m) | ($220.7m) | ($287.5m) | ($289.0m) | |
| Net loss | ($12.6m) | ($19.7m) | ($44.8m) | ($123.8m) | ($142.1m) | ($142.1m) | ($148.8m) | — | — | — | — | |
| Depreciation, Depletion and Amortization | $478k | $1.0m | $1.7m | $4.6m | $5.7m | $8.5m | $7.4m | $6.6m | $7.6m | $8.3m | $10.2m | |
| Depreciation | $478k | $1.0m | $1.7m | $4.6m | $5.7m | $8.6m | $7.3m | $6.6m | $7.6m | $8.3m | $8.5m | |
| Amortization of Intangible Assets | — | — | — | $47k | $91k | $90k | $65k | $0 | $162k | $1.5m | — | |
| Amortization Cash Flow | — | — | — | — | — | — | — | $0 | $162k | $1.5m | — | |
| Amortization Of Intangibles | — | — | — | — | — | — | — | $0 | $162k | $1.5m | $1.7m | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $7.4m | $6.6m | $7.7m | $9.8m | $10.2m | |
| Deferred Income Tax Expense (Benefit) | — | — | — | ($410k) | ($1.3m) | ($110k) | ($212k) | ($987k) | ($175k) | ($631k) | ($789k) | |
| Deferred income tax | — | $0 | $0 | ($399k) | ($1.3m) | ($72k) | ($268k) | ($986k) | ($185k) | ($286k) | ($789k) | |
| Deferred Tax | — | — | — | — | — | — | ($268k) | ($986k) | ($185k) | ($286k) | ($789k) | |
| Share-based Payment Arrangement, Expense | — | — | $6.8m | $30.4m | $20.0m | $9.9m | $12.0m | $11.2m | $15.5m | $14.4m | $15.1m | |
| Non-cash share-based compensation (net of amount capitalized) | $2.3m | $3.2m | $6.8m | $30.2m | $20.1m | $9.9m | $12.0m | — | — | — | — | |
| Capitalized share-based compensation, net of forfeitures | — | $0 | $0 | $174k | ($86k) | $0 | ($6k) | — | — | — | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | $0 | $0 | $0 | $0 | — | — | — | — | |
| Operating Lease, Impairment Loss | — | — | — | — | — | — | — | $382k | $414k | $349k | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $382k | $414k | $12.6m | $14.7m | |
| Other Nonoperating Income (Expense) | — | — | $4.0m | $4.5m | $1.4m | ($145k) | $2.0m | $2.9m | $220k | $515k | — | |
| Nonoperating Income (Expense) | — | — | $5.5m | $7.1m | $1.9m | ($988k) | ($5.2m) | ($28.7m) | $22.3m | ($15.0m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Change In Working Capital | — | — | — | — | — | — | $536k | $292k | ($23.7m) | ($52.0m) | ($50.8m) | |
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | — | — | — | — | $24.2m | ($13.5m) | |
| Change In Receivables | — | — | — | — | — | — | — | — | $0 | ($24.2m) | ($13.5m) | |
| Changes In Account Receivables | — | — | — | — | — | — | — | — | $0 | ($24.2m) | ($13.5m) | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | — | — | $4.2m | $40.2m | ($32.7m) | |
| Inventory Write-down | — | — | — | — | — | — | — | — | $0 | $12.3m | — | |
| Change In Inventory | — | — | — | — | — | — | — | $0 | ($4.2m) | ($40.2m) | ($32.7m) | |
| Increase (Decrease) in Accounts Payable | $507k | $434k | $838k | ($1.5m) | $1.4m | ($1.8m) | $22k | ($509k) | $1.6m | $1.3m | ($1.7m) | |
| Property and equipment purchases included in accounts payable or accrued expenses | $0 | $0 | $328k | $2.8m | $2.5m | $3.7m | $2.9m | — | — | — | — | |
| Issuance costs included in accounts payable and accrued expenses | — | — | — | — | — | $245k | $1.1m | — | — | — | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $16.0m | $489k | $13.5m | $2.3m | ($1.7m) | |
| Increase (decrease) in accrued expenses and other liabilities | — | $1.1m | $11.0m | $5.0m | $5.6m | ($2.0m) | $16.0m | — | — | — | ($9.7m) | |
| Capitalized implementation costs included in accrued expenses | — | — | — | $0 | $144k | $100k | $230k | — | — | — | — | |
| Change In Accrued Expense | — | — | — | — | — | — | $16.0m | $998k | $11.9m | $1.0m | ($9.7m) | |
| (Increase) decrease in prepaid expenses and other current assets | — | — | — | ($21.0m) | ($2.7m) | $5.6m | ($11.0m) | — | — | — | — | |
| Change In Other Current Liabilities | — | — | — | — | — | — | ($4.7m) | ($13.6m) | ($369k) | $14.6m | $18.7m | |
| Net Cash Provided by (Used in) Operating Activities | ($9.8m) |
($16.4m)
-66.11%
|
($31.5m)
-92.77%
|
($101.5m)
-221.79%
|
($117.8m)
-16.04%
|
($117.9m)
-0.09%
|
($112.3m)
+4.71%
|
($145.6m)
-29.63%
|
($206.3m)
-41.68%
|
($283.6m)
-37.47%
|
($273.3m)
+3.61%
|
|
| Cash flows from investing activities: | ||||||||||||
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | — | ($8k) | ($43k) | $0 | ($676k) | ($515k) | ($3.8m) | ($223k) | ($14k) | $2.3m | |
| Payments to Acquire Property, Plant, and Equipment | ($1.9m) | ($2.9m) | $9.1m | $18.3m | $14.7m | $8.9m | $10.8m | $11.0m | $22.1m | $19.0m | ($21.6m) | |
| Net Cash Provided by (Used in) Investing Activities | ($1.9m) | ($2.9m) | ($9.5m) | ($18.7m) | ($14.7m) | ($8.9m) | ($10.8m) | ($11.0m) | ($394.6m) | $158.5m | $314.2m | |
| Cash flows from financing activities: | ||||||||||||
| Issuance Of Capital Stock | — | — | — | — | — | — | $163.9m | $0 | $550.0m | $0 | $0 | |
| Proceeds from Issuance of Common Stock | — | — | $156.9m | $108.9m | $74.4m | $245.9m | $163.9m | $0 | $550.0m | $0 | $0 | |
| Common Stock Issuance | — | — | — | — | — | — | $163.9m | $0 | $550.0m | $0 | $0 | |
| Net Other Financing Charges | — | — | — | — | — | — | $59.6m | ($910k) | $39.0m | ($4.3m) | ($4.3m) | |
| Net Cash Provided by (Used in) Financing Activities | $32.2m |
$127.7m
+296.27%
|
$156.9m
+22.90%
|
$108.9m
-30.63%
|
$74.4m
-31.64%
|
$284.1m
+281.73%
|
$223.6m
-21.28%
|
($883k)
-100.39%
|
$589.6m
+66867.16%
|
($4.3m)
-100.74%
|
($6.4m)
-47.52%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | $17.9m | $109.0m | $110.0m | ($6.1m) | ($57.3m) | $156.6m | $72.1m | — | — | — | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($6.1m) | ($57.3m) | $156.6m | $72.1m | ($142.4m) | ($11.5m) | ($123.2m) | $131.7m | |
| Beginning Cash Position | — | — | — | — | — | — | $310.7m | $382.8m | $240.3m | $228.8m | $97.3m | |
| Cash, cash equivalents and restricted cash, beginning of period | $28.1m | $137.1m | $247.1m | $211.4m | $154.1m | $310.7m | $382.8m | — | — | — | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $5.2m | $679k | ($754k) | ($28.4m) | $15.0m | ($261k) | $6.3m | $732k | |
| Effect of exchange rate changes on cash and restricted cash | ($2.7m) | $561k | ($5.8m) | $5.2m | $679k | ($754k) | ($28.4m) | $15.0m | ($261k) | $6.3m | $732k | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $211.4m | $154.1m | $310.7m | $382.8m | $240.3m | $228.8m | $105.6m | $131.7m | |
| Short-term restricted cash | $0 | $0 | $105k | $787k | $786k | $338k | $325k | — | — | — | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Income Tax Expense (Benefit) | — | — | ($7.3m) | ($15.2m) | ($24.2m) | ($23.9m) | ($24.4m) | ($20k) | $1.5m | $2.0m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $9.3m | $36.7m | — | |
| Non-cash interest expense and cumulative catch-up adjustment | — | — | — | — | $0 | $1.1m | $8.9m | — | — | — | — | |
| Gain on termination of operating lease | — | — | — | $0 | ($160k) | $0 | $0 | — | — | — | — | |
| (Decrease) increase in current and non-current operating lease liabilities, net of operating lease right of use assets | — | — | — | ($552k) | ($3.5m) | ($2.4m) | ($1.3m) | — | — | — | — | |
| Leased assets terminated and obtained in exchange for operating lease liabilities, net | — | — | — | $0 | $2.5m | $28.5m | $0 | — | — | — | — | |
| Leased assets obtained in exchange for operating lease liabilities | — | — | — | $0 | $27.0m | $0 | $9.8m | — | — | — | — | |
| Additional Financial Items | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | — | — | — | $125k | $117k | $27k | $602k | $0 | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | $4.0m | $4.6m | $200k | $2.3m | $1.8m | $2.6m | ($989k) | $2.2m | — | |
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | — | — | — | — | ($4.0m) | $7.6m | ($1.9m) | $3.2m | — | |
| Gain (Loss) on Termination of Lease | — | — | — | — | $160k | $0 | $0 | ($95k) | ($176k) | $0 | — | |
| General and Administrative Expense | — | — | $22.8m | $39.5m | $35.0m | $31.9m | $31.9m | $46.7m | — | — | — | |
| Investment Income, Interest | — | — | $1.5m | $2.5m | $536k | $262k | $1.7m | $13.5m | $32.4m | $19.0m | — | |
| Operating Expenses | — | — | $57.5m | — | — | — | — | — | — | — | — | |
| Loss on disposal of fixed assets and intangible assets | — | $0 | $8k | $43k | $0 | $672k | $515k | — | — | — | — | |
| Foreign exchange differences | — | — | — | — | $0 | $0 | $4.0m | — | — | — | — | |
| Loss (gain) on lease incentive and reassessment | — | — | — | $0 | ($1.3m) | $9k | $0 | — | — | — | — | |
| Decrease (increase) in prepaid expenses and other non-current assets | ($2.0m) | ($2.3m) | ($7.1m) | ($21.0m) | ($2.6m) | $503k | $161k | — | — | — | — | |
| ( Increase) decrease in long-term deposits | $0 | $0 | $0 | ($702k) | ($508k) | $575k | ($5k) | — | — | — | — | |
| Proceeds of issuance of ordinary shares | $32.2m | $127.7m | $156.9m | $108.9m | $74.4m | $245.9m | $163.9m | — | — | — | — | |
| Proceeds from exercise of share options | — | — | — | $43k | $462k | $125k | $117k | — | — | — | — | |
| Proceeds from liability related to future royalties and sales milestones | — | — | — | $0 | $0 | $50.0m | $70.0m | — | — | — | — | |
| Payments of equity issuance costs | — | — | — | ($7.1m) | ($5.8m) | ($11.5m) | ($10.4m) | — | — | — | — | |
| Payments of issuance costs related to the liability related to the sale of future royalties and sales milestones | — | — | — | $0 | $0 | ($509k) | $0 | — | — | — | — | |
| Cash received for taxes | — | — | — | — | $21.6m | $25.0m | $20.0m | — | — | — | — | |
| Net cash received from taxes | — | — | — | — | $19.8m | $24.7m | $19.6m | — | — | — | — | |
| Warrants issued in relation to Blackstone Agreements at relative fair value | — | — | — | $0 | $0 | $9.9m | $0 | — | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $223.6m | ($883k) | $589.6m | ($4.3m) | ($6.4m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($10.8m) | ($11.0m) | ($394.6m) | $158.5m | $314.2m | |
| Change In Account Payable | — | — | — | — | — | — | $22k | ($509k) | $1.6m | $1.3m | ($1.7m) | |
| Change In Payable | — | — | — | — | — | — | $22k | ($509k) | $1.6m | $1.3m | ($1.7m) | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($10.8m) | $13.4m | ($32.6m) | ($4.6m) | ($7.1m) | |
| Changes In Cash | — | — | — | — | — | — | $100.5m | ($157.5m) | ($11.3m) | ($129.4m) | $34.4m | |
| End Cash Position | — | — | — | — | — | — | $382.8m | $240.3m | $228.8m | $105.6m | $131.7m | |
| Financing Cash Flow | — | — | — | — | — | — | $223.6m |
($883k)
-100.39%
|
$589.6m
+66867.16%
|
($4.3m)
-100.74%
|
($6.4m)
-47.52%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($123.1m) | ($156.6m) | ($241.1m) | ($310.7m) | ($294.9m) | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | $515k | $3.8m | $223k | $14k | $13k | |
| Investing Cash Flow | — | — | — | — | — | — | ($10.8m) | ($11.0m) | ($394.6m) | $158.5m | $314.2m | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | $4.0m | ($7.6m) | $1.9m | ($3.2m) | $2.2m | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | $0 | — | $0 | ($12.7m) | ($8.1m) | ($8.1m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($10.8m) | ($11.0m) | ($22.1m) | ($19.0m) | ($13.5m) | |
| Operating Gains Losses | — | — | — | — | — | — | $4.5m | ($3.8m) | $2.1m | ($3.2m) | $2.3m | |
| Other Non Cash Items | — | — | — | — | — | — | $12.3m | $49.2m | $12.5m | $22.5m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $117k | $27k | $602k | $0 | $0 | |
| Purchase Of Intangibles | — | — | — | — | — | $0 | — | $0 | ($12.7m) | ($8.1m) | ($8.1m) | |
| Purchase Of PPE | — | — | — | — | — | — | ($10.8m) | ($11.0m) | ($22.1m) | ($19.0m) | ($21.6m) | |
| Stock Based Compensation | — | — | — | — | — | — | $12.0m | $11.2m | $15.5m | $14.4m | $15.1m | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | — | $0 | ($359.7m) | $185.6m | $335.7m | |
| Purchase Of Investment | — | — | — | — | — | — | — | $0 | ($359.7m) | ($242.6m) | ($186.0m) | |
| Sale Of Investment | — | — | — | — | — | — | — | — | $0 | $428.2m | $521.8m | |
| Cash and cash equivalents | $28.1m | $137.1m | $247.1m | $210.6m | $153.3m | $310.3m | $382.4m | — | — | — | $97.3m | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $72.1m | ($142.4m) | ($11.5m) | ($123.2m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | $1.5m | $1.8m | — | — | — | — | — | — | |
| Income Taxes Paid, Net | — | $0 | $0 | $1.5m | $1.8m | $364k | ($19.6m) | $551k | $2.4m | $2.0m | — |